Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2011

01.05.2011 | Original Article

Protective Effects of Kurozu and Kurozu Moromimatsu on Dextran Sulfate Sodium-Induced Experimental Colitis

verfasst von: Toru Shizuma, Kazuo Ishiwata, Masanobu Nagano, Hidezo Mori, Naoto Fukuyama

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Kurozu, a traditional Japanese black vinegar made from unpolished rice, and Kurozu Moromimatsu (Kurozu-M), its sediment, are both consumed in Japan as health foods or supplements. However, it is not known whether they have anti-colitis activity.

Aims

We examined the protective effects of Kurozu and Kurozu-M in an animal model of dextran sulfate sodium (DSS)-induced colitis.

Methods

DSS-induced colitis was induced in C57 black 6 mice by orally administering 3.5% DSS solution for 12 days. The control group received basal CE-2 diet (n = 10), the Kurozu group received CE-2 containing Kurozu (n = 10), the Kurozu-M group received CE-2 containing Kurozu-M (n = 10), and the acetic acid group received CE-2 containing acetic acid (n = 10), starting a week before DSS administration. Changes of body weight and bloody stool frequency were monitored. At 12 days after DSS administration, mice were killed for pathological examination and measurement of nitrotyrosine levels in rectal tissues.

Results

Kurozu significantly inhibited body weight loss during 6–12 days after DSS administration and reduced bloody stool frequency during 2–12 days, and also significantly decreased nitrotyrosine levels at 12 days, compared to the control group. Kurozu-M significantly inhibited body weight loss during 6–8 days after DSS administration and reduced bloody stool frequency during 2–12 days, but tissue nitrotyrosine level was not significantly different from the control. Acetic acid had no ameliorating effect on DSS-induced colitis compared to the control group.

Conclusions

Kurozu and Kurozu-M have protective effects against DSS-induced colitis. Kurozu has anti-oxidative and anti-nitration activity.
Literatur
1.
Zurück zum Zitat Murooka Y, Yamashita M. Traditional healthful fermented products of Japan. J Ind Microbiol Biotechnol. 2008;35:791–798.PubMedCrossRef Murooka Y, Yamashita M. Traditional healthful fermented products of Japan. J Ind Microbiol Biotechnol. 2008;35:791–798.PubMedCrossRef
2.
Zurück zum Zitat Nakayama S, Saikawa M, Yamaura T, et al. Antihypertensive effect of Kurosu, extract: A traditional vinegar produced from unpolished rice, in SHR rats. Clin Pharm Ther. 2001;11:567–573. (in Japanese). Nakayama S, Saikawa M, Yamaura T, et al. Antihypertensive effect of Kurosu, extract: A traditional vinegar produced from unpolished rice, in SHR rats. Clin Pharm Ther. 2001;11:567–573. (in Japanese).
3.
Zurück zum Zitat Shimoji Y, Sugie S, Kohno H, et al. Extract of vinegar “Kurosu” from unpolished rice inhibits the development of colonic aberrant crypt foci induced by azoxymethane. J Exp Clin Cancer Res. 2003;22:591–597.PubMed Shimoji Y, Sugie S, Kohno H, et al. Extract of vinegar “Kurosu” from unpolished rice inhibits the development of colonic aberrant crypt foci induced by azoxymethane. J Exp Clin Cancer Res. 2003;22:591–597.PubMed
4.
Zurück zum Zitat Shimoji Y, Kohno H, Nanda K, et al. Extract of Kurosu, a vinegar from unpolished rice, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Nutr Cancer. 2004;49:170–173.PubMedCrossRef Shimoji Y, Kohno H, Nanda K, et al. Extract of Kurosu, a vinegar from unpolished rice, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Nutr Cancer. 2004;49:170–173.PubMedCrossRef
5.
Zurück zum Zitat Nanda K, Miyoshi N, Nakamura Y, et al. Extract of vinegar “Kurosu” from unpolished rice inhibits the proliferation of human cancer cells. J Exp Clin Cancer Res. 2004;23:69–75.PubMed Nanda K, Miyoshi N, Nakamura Y, et al. Extract of vinegar “Kurosu” from unpolished rice inhibits the proliferation of human cancer cells. J Exp Clin Cancer Res. 2004;23:69–75.PubMed
6.
Zurück zum Zitat Fukuyama N, Jujo S, Ito I, et al. Kurozu moromimatsu inhibits tumor growth of LoVo cells in a mouse model in vivo. Nutrition. 2007;23:81–86.PubMedCrossRef Fukuyama N, Jujo S, Ito I, et al. Kurozu moromimatsu inhibits tumor growth of LoVo cells in a mouse model in vivo. Nutrition. 2007;23:81–86.PubMedCrossRef
7.
Zurück zum Zitat Nishidai S, Nakamura Y, Torikai K, et al. Kurosu, a traditional vinegar produced from unpolished rice, suppresses lipid peroxidation in vitro and in mouse skin. Biosci Biotechnol Biochem. 2000;64:1909–1914.PubMedCrossRef Nishidai S, Nakamura Y, Torikai K, et al. Kurosu, a traditional vinegar produced from unpolished rice, suppresses lipid peroxidation in vitro and in mouse skin. Biosci Biotechnol Biochem. 2000;64:1909–1914.PubMedCrossRef
8.
9.
Zurück zum Zitat Hong SK, Chaturvedi R, Piazuelo MB, et al. Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity. Inflamm Bowel Dis. 2010;16:1557–1566.PubMedCrossRef Hong SK, Chaturvedi R, Piazuelo MB, et al. Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity. Inflamm Bowel Dis. 2010;16:1557–1566.PubMedCrossRef
10.
Zurück zum Zitat Schindhelm RK, van der Zwan LP, Teerlink T, et al. Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin Chem. 2009;55:1462–1470.PubMedCrossRef Schindhelm RK, van der Zwan LP, Teerlink T, et al. Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin Chem. 2009;55:1462–1470.PubMedCrossRef
11.
Zurück zum Zitat Radi R. Peroxynitrite and reactive nitrogen species: the contribution of ABB in two decades of research. Arch Biochem Biophys. 2009;484:111–113.PubMedCrossRef Radi R. Peroxynitrite and reactive nitrogen species: the contribution of ABB in two decades of research. Arch Biochem Biophys. 2009;484:111–113.PubMedCrossRef
12.
Zurück zum Zitat Beckman JS, Beckmen TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620–1624.PubMedCrossRef Beckman JS, Beckmen TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620–1624.PubMedCrossRef
13.
Zurück zum Zitat Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:179–189.PubMedCrossRef Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:179–189.PubMedCrossRef
14.
Zurück zum Zitat Akuta T, Zaki MH, Yoshitake J, et al. Nitrative stress through formation of 8-nitroguanosine: Insights into microbial pathogenesis. Nitric Oxide. 2006;14:101–108.PubMedCrossRef Akuta T, Zaki MH, Yoshitake J, et al. Nitrative stress through formation of 8-nitroguanosine: Insights into microbial pathogenesis. Nitric Oxide. 2006;14:101–108.PubMedCrossRef
15.
Zurück zum Zitat Ameho CK, Adjei AA, Harrison EK, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut. 1997;41:487–493.PubMedCrossRef Ameho CK, Adjei AA, Harrison EK, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut. 1997;41:487–493.PubMedCrossRef
16.
Zurück zum Zitat Grudziński IP, Frankiewicz-Jóźko A. Nitric oxide synthase inhibitors reduced lipid peroxidation in N-nitrosodiethylamine-treated rats. Rocz Panstw Zaki Hig. 2001;52:89–95. Grudziński IP, Frankiewicz-Jóźko A. Nitric oxide synthase inhibitors reduced lipid peroxidation in N-nitrosodiethylamine-treated rats. Rocz Panstw Zaki Hig. 2001;52:89–95.
17.
18.
Zurück zum Zitat Kim CJ, Kovacs-Nolan JA, Yang C, et al. L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis. Biochem Biophys Acta. 2009;1790:1161–1169.PubMed Kim CJ, Kovacs-Nolan JA, Yang C, et al. L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis. Biochem Biophys Acta. 2009;1790:1161–1169.PubMed
19.
Zurück zum Zitat Faure M, Mettraux C, Moennoz D, et al. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr. 2006;136:1558–1564.PubMed Faure M, Mettraux C, Moennoz D, et al. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr. 2006;136:1558–1564.PubMed
20.
Zurück zum Zitat Kim CJ, Kovacs-Nolan JA, Yang C, et al. l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem. 2010;21:468–475.PubMedCrossRef Kim CJ, Kovacs-Nolan JA, Yang C, et al. l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem. 2010;21:468–475.PubMedCrossRef
21.
Zurück zum Zitat Liao J, Seril DN, Yang AL, et al. Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds. Carcinogenesis. 2007;28:446–454.PubMedCrossRef Liao J, Seril DN, Yang AL, et al. Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds. Carcinogenesis. 2007;28:446–454.PubMedCrossRef
22.
Zurück zum Zitat Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620–1633.PubMedCrossRef Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620–1633.PubMedCrossRef
24.
Zurück zum Zitat Kanauchi O, Mitsuyama K, Andoh A. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Curr Pharm Des. 2009;15:2074–2086.PubMedCrossRef Kanauchi O, Mitsuyama K, Andoh A. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Curr Pharm Des. 2009;15:2074–2086.PubMedCrossRef
25.
Zurück zum Zitat Fujimori S, Gudis K, Mitsui K, et al. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition. 2009;25:520–525.PubMedCrossRef Fujimori S, Gudis K, Mitsui K, et al. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition. 2009;25:520–525.PubMedCrossRef
26.
Zurück zum Zitat Lee IH, Hung YH, Chou CC. Solid-state fermentation with fungi to enhance the antioxidative activity, total phenolic and anthocyanin contents of black bean. Int J Food Microbiol. 2008;121:150–156.PubMedCrossRef Lee IH, Hung YH, Chou CC. Solid-state fermentation with fungi to enhance the antioxidative activity, total phenolic and anthocyanin contents of black bean. Int J Food Microbiol. 2008;121:150–156.PubMedCrossRef
27.
Zurück zum Zitat Fukuda Y, Tao Y, Tomita T, et al. A traditional Japanese medicine mitigates TNBS-induced colitis in rats. Scand J Gastroenterol. 2006;41:1183–1189.PubMedCrossRef Fukuda Y, Tao Y, Tomita T, et al. A traditional Japanese medicine mitigates TNBS-induced colitis in rats. Scand J Gastroenterol. 2006;41:1183–1189.PubMedCrossRef
28.
Zurück zum Zitat Watanabe T, Nagawa H. Epidemiology of ulcerative colitis comparison between Japan and Western countries. Nippon Rinsho. 2005;63:750–756. (in Japanese).PubMed Watanabe T, Nagawa H. Epidemiology of ulcerative colitis comparison between Japan and Western countries. Nippon Rinsho. 2005;63:750–756. (in Japanese).PubMed
29.
Zurück zum Zitat van Lierop PP, Samsom JN, Escher JC, et al. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:142–151.PubMedCrossRef van Lierop PP, Samsom JN, Escher JC, et al. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:142–151.PubMedCrossRef
30.
Zurück zum Zitat Polińska B, Matowicka-Karna J, Kemona H. The cytokines in inflammatory bowel disease. Postepy Hig Med Dosw. 2009;63:389–394. Polińska B, Matowicka-Karna J, Kemona H. The cytokines in inflammatory bowel disease. Postepy Hig Med Dosw. 2009;63:389–394.
31.
Zurück zum Zitat Ghosh N, Chaki R, Mandal V, et al. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases. Int Rev Immunol. 2010;29:4–37.PubMedCrossRef Ghosh N, Chaki R, Mandal V, et al. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases. Int Rev Immunol. 2010;29:4–37.PubMedCrossRef
Metadaten
Titel
Protective Effects of Kurozu and Kurozu Moromimatsu on Dextran Sulfate Sodium-Induced Experimental Colitis
verfasst von
Toru Shizuma
Kazuo Ishiwata
Masanobu Nagano
Hidezo Mori
Naoto Fukuyama
Publikationsdatum
01.05.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1432-x

Weitere Artikel der Ausgabe 5/2011

Digestive Diseases and Sciences 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.